title: Targeting metabolism in breast cancer: How far we can go?
abstract: Adjuvant therapies for breast cancer have achieved great success in recent years and early breast cancer is now a curable or chronic disease. Targeted therapies, including endocrine therapy and human epidermal growth factor receptor-2 targeted therapy, marked a new era of breast cancer treatment. However, except for chemotherapy, an efficient drug treatment to improve the overall survival of breast cancer patients is still lacking for triple negative breast cancer. Furthermore, a certain proportion of breast cancer patients present with resistance to drug therapy, making it much more difficult to control the deterioration of the disease. Recently, altered energy metabolism has become one of the hallmarks of cancer, including breast cancer, and it may be linked to drug resistance. Targeting cellular metabolism is becoming a promising strategy to overcome drug resistance in cancer therapy. This review discusses metabolic reprogramming in breast cancer and the possible complex mechanism of modulation. We also summarize the recent advances in metabolic therapy targeted glycolysis, glutaminolysis and fatty acids synthesis in breast cancer.
authors: Jing-Pei Long, Xiao-Na Li, Department of Surgery, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, Zhejiang Province, China.
authors: Jing-Pei
authors: JP
authors: Long
authors: Jing-Pei Long, Xiao-Na Li, Department of Surgery, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, Zhejiang Province, China.
authors: Xiao-Na
authors: XN
authors: Li
authors: Jing-Pei Long, Xiao-Na Li, Department of Surgery, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, Zhejiang Province, China.
authors: Feng
authors: F
authors: Zhang
keywords: Breast cancer; Chemotherapy; Drug resistance; Metabolism; Targeted therapy